SCHEMBL4948064

SCHEMBL4948064

NC(=O)c1ccsc1-c1ccc(-c2ccc(C=O)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 2/20 0.50
ALDH1A1 P00352 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
MAPT P10636 1/20 0.46
MAPK1 P28482 1/20 0.46
PARP10 Q53GL7 1/20 0.40
PARP3 Q9Y6F1 1/20 0.40
PTK2 Q05397 1/20 0.39
GAA P10253 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MAPK10 P53779 3/20 0.36
MAPK8 P45983 2/20 0.36
ALDH5A1 P51649 1/20 0.35
ABAT P80404 1/20 0.35
CYP2A6 P11509 1/20 0.35
DRD1 P21728 1/20 0.34
ERN1 O75460 1/20 0.34
IKBKB O14920 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4952543 0.81 ALDH1A1 (0.55) PTGS1ALDH1A1MEN1KMT2AMAPT
SCHEMBL4948071 0.77 PTGS1 (0.54) PTGS1ALDH1A1HSD17B10ALDH5A1ABAT
SCHEMBL3595673 0.77 ALDH1A1 (0.50) PTGS1ALDH1A1MEN1KMT2AMAPT
SCHEMBL6623848 0.77 BCAT2 (0.55) PTGS1ALDH1A1MEN1KMT2AMAPT
SCHEMBL4951370 0.77 PTGS1 (0.55) PTGS1ALDH1A1MEN1KMT2AMAPT
SCHEMBL4951480 0.75 MEN1 (0.45) PTGS1ALDH1A1MEN1KMT2AMAPT
SCHEMBL4950473 0.74 MEN1 (0.43) PTGS1ALDH1A1MEN1KMT2AMAPT
SCHEMBL4950510 0.73 ERN1 (0.47) PTGS1ALDH1A1MEN1KMT2AMAPT
SCHEMBL19048679 0.72 PARP10 (0.69) ALDH1A1KMT2APARP10PARP3ERN1
SCHEMBL4952432 0.72 ADRB2 (0.48) ALDH1A1MEN1KMT2AMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893597-B1 AMPA RECEPTOR POTENTIATORS LILLY CO ELI (US) 2008-11-12 EP disclosed
US-7393868-B2 AMPA receptor potentiators ELI LILLY AND COMPANY (US) 2008-07-01 US disclosed
EP-1893597-A2 AMPA RECEPTOR POTENTIATORS ELI LILLY AND COMPANY (US) 2008-03-05 EP disclosed
US-20070142441-A1 AMPA receptor potentiators ELI LILLY AND COMPANY 2007-06-21 US disclosed
WO-2006132811-A2 AMPA RECEPTOR POTENTIATORS ELI LILLY AND COMPANY (US) 2006-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142441-A1 AMPA receptor potentiators GABRE, GRIN1, GRIK2 PTGS1 1216/4885ALDH1A1 928/4885MEN1 4077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.